Table of Content

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Alzheimer’s Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Drug Class
6.1 Donepezil
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Galantamine
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Rivastigmine
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Memantine
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast

7 Market Breakup by Distribution Channel
7.1 Hospital Pharmacy
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Retail Pharmacy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Online Stores
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast

8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast

9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Abbvie Inc.
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 AstraZeneca PLC
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Biogen Inc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Daiichi Sankyo Company Limited
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 Eisai Co. Ltd.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Eli Lilly and Company
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 H. Lundbeck A/S
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 F. Hoffmann-La Roche AG
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 SWOT Analysis
13.3.9 Merck & Co. Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Novartis AG
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Ono Pharmaceutical Co. Ltd.
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.11.4 SWOT Analysis
13.3.12 Pfizer Inc.
13.3.12.1 Company Overview
13.3.12.2 Product Portfolio
13.3.12.3 Financials
13.3.12.4 SWOT Analysis
13.3.13 Teva Pharmaceutical Industries Limited
13.3.13.1 Company Overview
13.3.13.2 Product Portfolio
13.3.13.3 Financials
13.3.13.4 SWOT Analysis

List of Figures

Figure 1: Global: Alzheimer’s Drugs Market: Major Drivers and Challenges
Figure 2: Global: Alzheimer’s Drugs Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Alzheimer’s Drugs Market: Breakup by Drug Class (in %), 2021
Figure 4: Global: Alzheimer’s Drugs Market: Breakup by Distribution Channel (in %), 2021
Figure 5: Global: Alzheimer’s Drugs Market: Breakup by Region (in %), 2021
Figure 6: Global: Alzheimer’s Drugs Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 7: Global: Alzheimer’s Drugs (Donepezil) Market: Sales Value (in Million US$), 2016 & 2021
Figure 8: Global: Alzheimer’s Drugs (Donepezil) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 9: Global: Alzheimer’s Drugs (Galantamine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Alzheimer’s Drugs (Galantamine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Alzheimer’s Drugs (Rivastigmine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Alzheimer’s Drugs (Rivastigmine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Alzheimer’s Drugs (Memantine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Alzheimer’s Drugs (Memantine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Alzheimer’s Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Alzheimer’s Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Alzheimer’s Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Alzheimer’s Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Alzheimer’s Drugs (Retail Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Alzheimer’s Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Alzheimer’s Drugs (Online Stores) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Alzheimer’s Drugs (Online Stores) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Alzheimer’s Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Alzheimer’s Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: North America: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: North America: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: United States: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: United States: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Canada: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Canada: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Asia Pacific: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Asia Pacific: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: China: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: China: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Japan: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Japan: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: India: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: India: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: South Korea: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: South Korea: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Australia: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Australia: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Indonesia: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Indonesia: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Others: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Others: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Europe: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Europe: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Germany: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Germany: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: France: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: France: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: United Kingdom: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: United Kingdom: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Italy: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Italy: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Spain: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Spain: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Russia: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Russia: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Others: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Others: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Latin America: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Latin America: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Brazil: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Brazil: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Mexico: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Mexico: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Others: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Others: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Middle East and Africa: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Middle East and Africa: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Global: Alzheimer’s Drugs Industry: SWOT Analysis
Figure 74: Global: Alzheimer’s Drugs Industry: Value Chain Analysis
Figure 75: Global: Alzheimer’s Drugs Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Alzheimer’s Drugs Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Alzheimer’s Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
Table 3: Global: Alzheimer’s Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 4: Global: Alzheimer’s Drugs Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 5: Global: Alzheimer’s Drugs Market: Competitive Structure
Table 6: Global: Alzheimer’s Drugs Market: Key Players